Best Health and Medical Grants in Iowa

The PhRMA Foundation's Translational Medicine Faculty Starter Grant supports early-career researchers at U.S. universities, providing $100,000 for one year. This grant emphasizes innovative research that translates laboratory findings into clinical applications, addressing unmet medical needs. Applicants must be within five years of independent status and collaborate with clinical partners. The program aims to foster a patient-centric approach in translational medicine, enhancing the development of new diagnostics and therapies for improved patient care.

The Value Assessment and Health Outcomes Research Faculty Starter Grant, offered by the PhRMA Foundation, supports emerging researchers at U.S. universities. With a funding of $100,000 for one year, it aims to advance studies on the effectiveness and value of healthcare interventions. The grant promotes innovative research in areas such as clinical outcomes, health equity, and patient engagement, ensuring that diverse perspectives are included in the evaluation of healthcare solutions.

The Value Assessment and Health Outcomes Research Predoctoral Fellowship, offered by the PhRMA Foundation, supports promising students in their advanced training and thesis research. This fellowship, aimed at U.S. and non-U.S. citizens, provides $30,000 in annual stipend support for up to two years. It encourages research proposals that address the effectiveness, safety, and value of healthcare interventions, emphasizing patient engagement and health equity in the evaluation process.

The Value Assessment and Health Outcomes Research Postdoctoral Fellowship, funded by the PhRMA Foundation, offers a $60,000 stipend annually for up to two years. This fellowship supports researchers, both U.S. and non-U.S. citizens, engaged in innovative studies aimed at evaluating the effectiveness and value of healthcare interventions. Applicants must be within five years of postdoctoral study and hold a relevant doctoral degree. This opportunity fosters collaboration and patient engagement in health outcomes research.

The ARS Women in Rhinology Research Grant, sponsored by Medtronic, offers $25,000 for one year to support innovative research in rhinology. Eligible applicants must be members of the American Rhinologic Society who have completed their residency, with at least one female investigator involved. The award covers legitimate research costs, with a detailed budget required. Results must be presented at an ARS national meeting, acknowledging the grant's support. This initiative fosters women's contributions to rhinology research.

The ARS Friends in Research Award, funded by the American Rhinologic Society, offers $25,000 over two years to support innovative research in rhinology. Eligible candidates include members who have completed residency without significant outside funding. The award encourages early and mid-career investigators to explore diverse areas within rhinology. Recipients can publish their findings, with the society retaining first refusal rights for publication. This grant aims to foster career development in the field of rhinology.

The AHNS Presidential Award supports innovative research focused on understanding treatment resistance in head and neck cancer. With a funding amount of $10,000 for one year, eligible candidates include medical students, residents, and faculty at the associate professor level or below who are AHNS members in good standing. Projects must demonstrate a translational focus and collaboration across disciplines, aiming to yield actionable insights within the award period.

The AHNS Presidential Award supports innovative research targeting novel therapeutic approaches in head and neck cancer. With a funding amount of $15,000 for one year, this grant encourages projects that utilize advanced methodologies such as genomics and immune profiling. Applicants must be AHNS members in good standing and provide letters of support from their institution. The goal is to foster research that can lead to significant advancements in treatment strategies for this challenging disease.

The CORE Funding - AHNS/AAO-HNSF Young Investigator Research Development Award offers $50,000 over two years to support early-career head and neck surgeons in developing research skills in neoplastic disease. This award encourages collaborative projects and requires applicants to submit a detailed budget and letters of support from key personnel. Priority is given to junior faculty and those introducing innovative methodologies. This funding serves as a stepping stone for future NIH grant applications.

The CORE Funding: AHNS/AAO-HNSF Translational Innovator Award supports innovative research in head and neck neoplastic diseases with a grant of $100,000 over two years. Eligible applicants include full-time academic head and neck surgeons, who must demonstrate a commitment to developing independent research careers. The award encourages interdisciplinary collaboration and aims to yield significant findings within the funding period, fostering long-term research potential and attracting further funding opportunities.

The AAO-HNSF/ANS Herbert Silverstein Otology/Neurotology Research Award supports innovative clinical or basic science research focused on auditory and vestibular diseases. Established by Herbert Silverstein, MD, this award aims to assist young academic investigators in launching new projects. Since 2000, it has funded seven grants totaling $175,000, emphasizing projects with clear clinical relevance and potential for future funding. Applicants must demonstrate commitment to research and secure institutional support, with a priority for junior faculty and fellows.

The AAO-HNSF Percy Memorial Research Award offers $25,000 for one year to support innovative research projects in otolaryngology-head and neck surgery. This grant aims to fund projects with clinical significance, encouraging the development of new long-term research initiatives. Applicants must submit a detailed budget and secure letters of support from their Department Chair and key personnel involved in the project. Funds cannot cover salaries or purchase equipment exceeding $500.

The NIH R25 program aims to enhance inclusivity in research education by supporting activities that encourage individuals from diverse backgrounds to pursue careers in substance use and addiction sciences. This initiative focuses on skills development courses and research experiences, particularly targeting underrepresented groups in biomedical and behavioral sciences. Applications are due by 5:00 PM local time of the applicant organization, with optional Letters of Intent encouraged 30 days prior to the full proposal deadline.

The Limited Competition Small Grant Program supports NCATS CTSA Program KL2 scholars, enhancing their transition to independent academic translational scientists. This R03 funding facilitates various research projects, including pilot studies and methodology development, aimed at generating preliminary data for future R01 applications. The program is designed for short-term projects utilizing limited resources, promoting innovative research in clinical and translational science.

The NCI Pathway to Independence Award (K99/R00) supports early-stage postdoctoral researchers transitioning to independent faculty positions. This funding opportunity encourages talented individuals with clinical or research doctoral degrees to lead independent clinical trials. Applicants should aim to foster research careers in cancer control, prevention, and data sciences. This initiative provides essential support during the transition from mentored positions to independent research roles, enhancing the pool of independent investigators in cancer research.

The NCI Pathway to Independence Award (K99/R00) aims to support early-stage postdoctoral researchers transitioning to independent faculty positions. This initiative focuses on talented individuals with doctoral degrees in research or clinical fields, providing essential NCI funding during this key career juncture. Researchers engaged in cancer control, prevention, and data sciences are encouraged to apply for this opportunity, which emphasizes experimental studies with human participants, thus aligning with NIH's clinical trial definitions.

The NIH Pathway to Independence Award (K99/R00) program is designed to support promising postdoctoral researchers in transitioning to independent faculty positions. This initiative aims to maintain a strong cohort of talented investigators by providing independent NIH research funding during this critical phase. Key application deadlines span from June 2024 to February 2027, encouraging applications from diverse fields, including AIDS-related research.

The NIH Pathway to Independence Award (K99/R00) supports the transition of postdoctoral researchers to independent faculty positions. It aims to enhance the number of talented NIH-supported investigators by providing funding during their transition to independent research careers. Key deadlines for applications are set for various dates through 2027. This program is crucial for developing a strong cohort of new independent researchers, fostering innovation in health-related fields.

The NIH Pathway to Independence Award (K99/R00) aims to enhance the career development of promising postdoctoral researchers by transitioning them into independent faculty positions. This program supports innovative research during the critical transition phase, enabling awardees to establish successful, independent research careers. Key application deadlines span from June 2024 to February 2027, with specific dates for standard, renewal, and AIDS-related applications. This initiative is vital for fostering a new generation of NIH-supported investigators.

The NIH Mentored Research Scientist Development Award (K01) aims to support early-career researchers in the biomedical, behavioral, or clinical sciences. This program provides three to five years of protected time for intensive career development, paving the way to research independence. Various NIH Institutes leverage this award to assist individuals transitioning into new fields or re-engaging with research after personal challenges. The K01 is a vital resource for cultivating the next generation of scientific leaders.

The NIH Independent Scientist Award (K02) supports the development of outstanding scientists by providing three to five years of salary support and protected time for newly independent researchers. This funding opportunity is specifically for applicants proposing research that does not involve leading an independent clinical trial, allowing them to gain experience in trials led by others. Key deadlines for applications span from June 2024 to February 2027.

The NIH Independent Scientist Award (K02) aims to support the development of independent scientists and enhance their research capabilities. This award offers salary support and protected time for three to five years, specifically for those leading independent clinical trials or feasibility studies. Applicants must demonstrate a need for focused research to advance their careers. Key deadlines for applications span from June 2024 to February 2027, catering to various submission types including standard and AIDS-related grants.

The Mentored Clinical Scientist Research Career Development Award (K08) supports individuals with clinical doctoral degrees to pursue intensive research training. This program focuses on developing skills in biomedical and behavioral research, addressing national health-related research needs. Key deadlines for applications span from June 2024 to February 2027, with specific dates for standard, renewal, and AIDS-related grants, ensuring that qualified candidates have ample opportunity to apply and advance their research careers.

The Mentored Clinical Scientist Research Career Development Award (K08) supports individuals with clinical doctoral degrees to develop their research careers in biomedical and behavioral fields. This program emphasizes a structured mentoring approach, aiming to address the nation's health-related research needs. Key application deadlines include June 12, 2024, and October 12, 2024, among others, providing opportunities for both new and renewal submissions.

The NIH Mentored Clinical Scientist Research Career Development Award (K08) aims to develop the research careers of individuals with clinical doctoral degrees. This program provides essential support and protected time for intensive, supervised research experiences in biomedical and behavioral fields, including translational research. Important deadlines for applications span from June 2024 to February 2027, accommodating various grant types, including standard and AIDS-related applications.

The NIH Mentored Research Scientist Development Award (K01) supports early-career scientists with up to five years of protected time for intensive research training in biomedical, behavioral, or clinical sciences. This award is tailored for those pursuing independence in research and is particularly beneficial for individuals transitioning fields or returning from a hiatus. Importantly, applicants must not lead independent clinical trials but may participate in trials overseen by mentors.